CATEGORIES

Clinical Trials

LATEST

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Dallas Researchers Recruiting for Pediatric Migraine Clinical Trial

Cedar Health Research, located in Dallas and Irving, is currently enrolling candidates in two clinical trials to evaluate the safety and tolerability of Rimegepant

Texas: Migraine Clinical Study Participants – Men and Women

Apply to Cedar Health to participate in a clinical study about Migraines. This study is open to both male and female participants. Migraines

Forget Hype – Digital Therapeutic Data Show the Category Can be Held to High Clinical Standards

New Study Points to a Strong Possibility that Digital Health Can Advance Migraine Care Treatment